More articles from Editorial

You have access
Reflections on the withdrawal of medical articles and the development of writing and publishing standards
Lidong Wang and Zhihua Liu

Cancer Biology & Medicine September 2022, 19 (9) 1283-1289; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0437
You have access
Update on diffuse large B-cell lymphoma: highlights from the 2022 ASCO Annual Meeting
Minghan Qiu, Shan Wu, Xinrui Chen and Huaqing Wang

Cancer Biology & Medicine August 2022, 19 (8) 1117-1120; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0403
You have access
Rosiglitazone disrupts pancreatic ductal adenocarcinoma progression by activating the tumor suppressor ESE3/EHF
Hongquan Wang, Shuang Wu, Yan Wang and Bo Tang

Cancer Biology & Medicine July 2022, 19 (7) 945-947; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0299
You have access
Chinese Society of Clinical Oncology Breast Cancer (CSCO BC) guidelines in 2022: stratification and classification
Jianbin Li and Zefei Jiang

Cancer Biology & Medicine June 2022, 19 (6) 769-773; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0277
You have access
PD-1 inhibitors provide new opportunities in conversion therapy for stage IV gastric cancer
Han Liang

Cancer Biology & Medicine May 2022, 19 (5) 565-568; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0244
You have access
Highlighted multi-modifications of enzymes: a novel succinylation mediated by histone acetyltransferase 1 in tumors
Xiaodong Zhang, Chunyu Hou and Guang Yang

Cancer Biology & Medicine February 2022, 19 (2) 133-135; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0533
You have access
A CRISPR-Cas9 screen shows the combination efficacy of lenvatinib plus epidermal growth factor receptor inhibitors for treatment of liver cancer
Yuchen Guo, Yangyang Zhou and Wenxin Qin

Cancer Biology & Medicine February 2022, 19 (2) 136-139; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0520
You have access
The emerging role of long noncoding RNA RMRP in cancer development and targeted therapy
Qian Hao and Xiang Zhou

Cancer Biology & Medicine February 2022, 19 (2) 140-146; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0577
You have access
Epigenetic modulation of the tumor immune microenvironment by nanoinducers to potentiate cancer immunotherapy
Ning Zhang and Xishan Hao

Cancer Biology & Medicine January 2022, 19 (1) 1-3; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0514
You have access
Deep proteome profiling promotes whole proteome characterization and drug discovery for esophageal squamous cell carcinoma
Wei Liu, Yongping Cui, Wen Liu, Zhihua Liu, Liyan Xu and Enmin Li

Cancer Biology & Medicine March 2022, 19 (3) 273-277; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0024

Main menu

User menu

Search

More articles from Editorial

Pages

Navigate

More Information

For Authors

Journal Services